Skip Navigation
Skip to contents

IMKASID 2024

Menu View
End Today : 2025-11-04
  • Twitter
Menu Close

Home

Program
Invited Speakers

Invited Speakers

검색

Day 3 – April 13 (Sat)

[Breakfast with Master 4] Discovering Optimal Approaches for Lifelong Care in UC April 13 (Sat), 07:30-08:00 | Room B
  • Optimal Position of Advanced Therapies to Improve Long-term Outcomes in UC Sang Hyoung Park University of Ulsan
    Korea

Day 3 – April 13 (Sat)

[Symposium 5] Cutting-edge Issues in IBD April 13 (Sat), 08:30-10:00 | Room A
  • Prevention and Early Detection of IBD Joyce Wing Yan Mak The Chinese University of Hong Kong
    Hong Kong, China
  • Bowel Strictures in Crohn's Disease: How to Prevent and Treat in Clinical Practice Jun Hwan Yoo CHA University
    Korea
  • Caring Women with IBD and Their Children Shu-Chen Wei National Taiwan University
    Taiwan

Day 3 – April 13 (Sat)

[Symposium 6] Innovations in Artificial Intelligence for Intestinal Research April 13 (Sat), 08:30-10:00 | Room B
  • Development of AI-assisted Colonoscopy in Inflammatory Bowel Disease Kazuo Ohtsuka Tokyo Medical and Dental University Hospital
    Japan
  • Expectations and Challenges of Colonoscopies with AI Sravanthi Parasa Swedish Medical Center
    USA
  • Use of Natural Language Processing for Intestinal Diseases: From Rule-Based Programming to Generative AI Jung Ho Bae Seoul National University
    Korea

Day 3 – April 13 (Sat)

[Special Session] Tracing Success: The Evolution and Impact of KASID Guidelines April 13 (Sat), 10:15-11:35 | Room A
  • Process of Creating Guidelines: Methodology Seong-Eun Kim Ewha Womans University
    Korea
  • Do’s and Don’ts Based on CDI Guidelines Young-Seok Cho The Catholic University of Korea
    Korea
  • Key Points in Treating Intestinal Behcet's Disease: Insights Post-Guideline Creation Soo-Young Na The Catholic University of Korea
    Korea
  • Reflecting on the History and Clinical Impact of KASID's Guidelines Chang Hwan Choi Chung-Ang University
    Korea

Day 3 – April 13 (Sat)

[Symposium 7] Decoding the Connection: Diet and Intestinal Diseases April 13 (Sat), 10:15-11:35 | Room B
  • Reappraisal of Diet as a Therapeutic Approach in Adults with IBD Peter Gibson Monash University
    Australia
  • Enteral Nutrition for Management of Pediatric IBD Jin Soo Moon Seoul National University
    Korea
  • Dietary Supplement Use and Colorectal Cancer Risk NaNa Keum Dongguk University
    Korea

Day 3 – April 13 (Sat)

[Luncheon Symposium 7] April 13 (Sat), 12:25-13:05 | Room A
  • ZEPOSIA, a First in Class S1PR Modulator with Proven Clinical Efficacy Won Moon Kosin University
    Korea
  • Practical Guidelines and Long-term Experience on ZEPOSIA in Treatment of UC Sang-Bum Kang The Catholic University of Korea
    Korea

Day 3 – April 13 (Sat)

[Luncheon Symposium 8] April 13 (Sat), 13:05-13:45 | Room A
  • Cumulated Knowledge on JAKi -The Data Legacy of Tofacitinib in UC Sung Hoon Jung The Catholic University of Korea
    Korea
  • Optimizing Treatment Options -Right Patient of Tofacitinib Soo-Young Na The Catholic University of Korea
    Korea

Day 3 – April 13 (Sat)

[Luncheon Symposium 9] April 13 (Sat), 12:25-13:05 | Room B
  • The Practical Application of 5-ASA as the Gold Standard in UC Treatment: Past, Present, and Future Perspectives Yoon-Kyo An The University of Queensland
    Australia
  • Enhancing UC Treatment: Combine PENTASA® Oral +Rectal Suppository for Comprehensive Relief Seong-Joon Koh Seoul National University
    Korea

Day 3 – April 13 (Sat)

[Luncheon Symposium 10] Therapeutic Approaches for Better Patient Outcome April 13 (Sat), 13:05-13:45 | Room B
  • Reasonable Therapeutic Approach: Role of JAK inhibitors in UC Bora Keum Korea University
    Korea
  • Positioning Filgotinib in the Treatment Algorithm of UC Kyeong Ok Kim Yeungnam University
    Korea

Day 3 – April 13 (Sat)

[Nurse and Dietitian Session] Clinical and Nutritional Approaches to IBD: Diet, Care, and Therapies (KOR) April 13 (Sat), 13:55-15:15 | Room B
  • The Role of Food and Environmental Factors in the Pathogenesis of IBD Seung Yong Shin Chung-Ang University
    Korea
  • Contributions of IBD Nurses to the Field of Gut Microbiome Research Jaewook Shin Seoul National University Hospital
    Korea
  • Conventional and Advanced Therapies in IBD Dong Hyun Kim Chonnam National University
    Korea
  • Dietary and Nutrition Counseling for IBD Patients Seokyung Park Kyung Hee University Medical Center
    Korea

Day 3 – April 13 (Sat)

[KASID Presidential Plenary Session] April 13 (Sat), 15:25-17:05 | Room A
  • [Plenary 1] Breaking the Therapeutic Ceiling: Precision Medicine for Personalized Care of IBD Byong Duk Ye University of Ulsan
    Korea
  • [Plenary 2] Breaking the Therapeutic Ceiling: Integrating Evidence to Select Biologics and Small Molecules for IBD: What Clinicians Should Know Parambir S Dulai Northwestern University Feinberg School of Medicine
    USA
Diamond
  • abbvie
  • CELLTRION PHARM
  • Jassen
  • SAMSUNG BIOEPIS
  • Takeda
Platinum
  • Bristrol Myers Squibb
  • DEAWOONG
  • FERRING PHARMACEUTICALS
Gold
  • Eisasi Korea Inc.
  • Pfizer
Bronze
  • GSK
  • Pharmbio Korea Inc.
  • TAEJOON

Go Top

Korean Association for the Study of Intestinal Diseases
31, Seolleung-ro 86 Gil, Gangnam-Gu, Seoul, 06193, Korea
IMKASID 2024 Secretariat [People-x, Inc.]
  • 1F, Haeoreum B/D, 16, Yeoksam-ro 17-gil, Gangnam-gu, Seoul, 06246, Korea
    [All Inquiries] info@imkasid.kr
    [Scientific Program/Abstract] +82-2-566-5951
    [Registration] +82-70-4895-6139
    [Sponsorship] +82-70-4895-6110

Copyright ⓒ Korean Association for the Study of Intestinal Diseases All rights reserved